Genelux Insider Trades

GNLX

Track insider trading activity from Genelux executives and directors. See which insiders are buying and selling GNLX stock.

Trades Last 12 Months

GNLX Price

All Insider Trades for Genelux

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cappello Joseph Chief Technical Officer
Holding Value $662k 318,480 shares
Last Trade
Aug 31, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$28.1k 10,257 shares
$2.74
$2.08
Yu Yong Chief Scientific Officer
Holding Value $538k 258,688 shares
Last Trade
Aug 31, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$26.6k 9,683 shares
$2.75
$2.08
Zindrick Thomas President And CEO
Holding Value $2.55M 1,226,427 shares
Last Trade
Aug 31, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$92k 34,463 shares
$2.67
$2.08
Smither John W Director
Holding Value $190k 91,403 shares
Last Trade
Jul 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$34.9k 12,000 shares
$2.91
$2.08
Pulisic Matthew Chief Financial Officer
Holding Value $580k 278,906 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$826k 278,906 shares
$2.96
$2.08
Mirabelli Mary Director
Holding Value $214k 102,693 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$178k 59,975 shares
$2.96
$2.08
Thomas John Director
Holding Value $1.04M 501,193 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$178k 59,975 shares
$2.96
$2.08
Tyree James L Director
Holding Value $201k 96,483 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$178k 59,975 shares
$2.96
$2.08
Groen Eric General Counsel
Holding Value $487k 233,957 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$693k 233,957 shares
$2.96
$2.08
Smalling Ralph Head Of Regulatory
Holding Value $141k 67,611 shares
Last Trade
Jun 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$563 192 shares
$2.93
$2.08
Ryder Sean General Counsel
Holding Value $99.1k 47,621 shares
Last Trade
May 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.1k 4,475 shares
$2.92
$2.08
Zak Lourie S. Chief Financial Officer
Holding Value $172k 82,452 shares
Last Trade
Dec 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 56,525 shares
$2.29
$2.08
Scigalla Paul Chief Medical Officer
Holding Value $34.7k 16,666 shares
Last Trade
Oct 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.8k 16,666 shares
$2.75
$2.08
Szalay Aladar 10% owner
Holding Value $1.25M 599,821 shares
Last Trade
Sep 13, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$85k 33,080 shares
$2.57
$2.08
Jewett Caroline Head Of Quality
Holding Value $33.6k 16,174 shares
Last Trade
Jun 24, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.5k 4,961 shares
$2.12
$2.08
Samuelson Doug Vice President, Finance
Holding Value $83.2k 40,000 shares
Last Trade
Sep 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$896k 40,000 shares
$22.40
$2.08
Yu Tony Vp, Clinical Trial Operations
Holding Value $331k 159,000 shares
Last Trade
Feb 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.1k 9,000 shares
$6.57
$2.08
Zhang Qian Associate Vp, Research
Holding Value $290k 139,333 shares
Last Trade
Feb 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.4k 6,000 shares
$6.57
$2.08
Woodward Gabe Director
Holding Value $8.71k 4,186 shares
Last Trade
Feb 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.57k 1,000 shares
$6.57
$2.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up